Profile
Hakim Larbi Bouterfa is the founder of OctreoPharm Sciences GmbH, founded in 2009.
Dr. Bouterfa is also the founder of PentixaPharm GmbH.
Currently, Dr. Bouterfa is the Managing Partner at 1717 Life Sciences Ventures GmbH since 2017.
Formerly, Dr. Bouterfa was Medical Director-Sandostatin Franchise at Novartis Pharma GmbH, Managing Director & VP-European Operations at Molecular Insight Pharmaceuticals GmbH, Chief Medical Officer at Eckert & Ziegler SE in 2023, and Member of the Supervisory Board at Pentixapharm Holding AG from 2024 to 2025.
Hakim Bouterfa active positions
| Companies | Position | Start |
|---|---|---|
1717 Life Sciences Ventures GmbH
1717 Life Sciences Ventures GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 31/12/2016 |
Former positions of Hakim Bouterfa
| Companies | Position | End |
|---|---|---|
PentixaPharm GmbH
PentixaPharm GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotech company that discovers and develops novel targeted radiopharmaceuticals | Chief Executive Officer | 26/10/2024 |
| ECKERT & ZIEGLER SE | Chief Tech/Sci/R&D Officer | 30/12/2023 |
Novartis Pharma GmbH
Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Corporate Officer/Principal | - |
Molecular Insight Pharmaceuticals GmbH
Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops and commercializes innovative molecular imaging pharmaceuticals | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler Strahlen- und Medizintechnik AG Medical SpecialtiesHealth Technology Provides isotope technology for medical, scientific and industrial use | Health Technology |
Novartis Pharma GmbH
Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Molecular Insight Pharmaceuticals GmbH
Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops and commercializes innovative molecular imaging pharmaceuticals | Health Technology |
1717 Life Sciences Ventures GmbH
1717 Life Sciences Ventures GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
PentixaPharm GmbH
PentixaPharm GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotech company that discovers and develops novel targeted radiopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Hakim Bouterfa
















